Health Condition 1: E889- Metabolic disorder, unspecified
Conditions
Interventions
Intervention1: Alpha lipoic acid: Alpha lipoic acid is a caprylic acid derived antioxidant for 12 weeks
Control Intervention1: Placebo: Placebo is a starch compound will be looks similar like alpha li
Sponsors
Vijayalakshmi M
Eligibility
Inclusion criteria
Inclusion criteria: Female patients whose bmi is above 23kg/m2 who is diagnosed with PCOS 7 taking metformin for a period 3 months
Exclusion criteria
Exclusion criteria: Breastfeeding, Lactation mothers Females affected by renal disease, liver disease, cardiac disease H/o pt taking alcohol Pcos pts who is on hormonal treatment
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Improvement in Insulin sensitivity by estimating HOMA-IR from baseline to 12 weeks in overweight &obese PCOS patientsTimepoint: Improvement in Insulin sensitivity by estimating HOMA-IR from baseline to 12 weeks in overweight &obese PCOS patients | — |
Secondary
| Measure | Time frame |
|---|---|
| Improvement in liver index scores by measuring lipid accumulation product hepatic steatosis index from baseline to 12 weeksTimepoint: 12 weeks | — |
Countries
India
Contacts
Public ContactDr Sangeetha Raja
SRM medical college hospital research instiute
Outcome results
None listed